Building Blocks
Esta sección contiene productos fundamentales para la síntesis de compuestos orgánicos y biológicos. Building blocks son los materiales de partida esenciales utilizados para construir moléculas complejas a través de diversas reacciones químicas. Desempeñan un papel crítico en el descubrimiento de fármacos, la ciencia de materiales y la investigación química. En CymitQuimica, ofrecemos una gama diversa de building blocks de alta calidad para apoyar sus investigaciones innovadoras y proyectos industriales, asegurando que tenga los componentes esenciales para una síntesis exitosa.
Subcategorías de "Building Blocks"
- Ácidos borónicos y derivados del ácido borónico(5.778 productos)
- Building Blocks quirales(1.243 productos)
- Building Blocks de hidrocarburos(6.097 productos)
- Building Blocks orgánicos(61.048 productos)
Se han encontrado 203115 productos de "Building Blocks"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2,3-Dihydro-1H-pyrrolo[3,2-c]pyridine
CAS:<p>2,3-Dihydro-1H-pyrrolo[3,2-c]pyridine is an alkaloid compound that has various applications in research and chemical studies. It has been found to interact with dopamine receptors and exhibit photothermal properties. This compound has been studied in the context of G. lucidum (also known as Reishi mushroom) and its potential therapeutic effects. Additionally, it has shown interactions with quinpirole, lithium, ergovaline, efrotomycin, and other compounds. The photocatalytic and fatty acid properties of 2,3-Dihydro-1H-pyrrolo[3,2-c]pyridine make it a versatile compound for various research purposes.</p>Pureza:Min. 95%3-aminopyrrolidin-2-one hcl
CAS:<p>3-Aminopyrrolidin-2-one hcl is an antibiotic that is used to treat tuberculosis. It inhibits the enzyme transacylase, which catalyses the conversion of L-lysine into L-pipecolic acid in bacteria. This antibiotic has been shown to be effective against Mycobacterium tuberculosis and Mycobacterium avium complex. 3-Aminopyrrolidin-2-one hcl has a broad spectrum of activity against gram positive and gram negative bacteria, but it is not active against acid-fast bacteria.</p>Fórmula:C4H9ClN2OPureza:Min. 95%Peso molecular:136.58 g/mol3-bromo-6,7-dihydro-5h-pyrrolo[3,4-b]pyridine hcl
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C7H8BrClN2Pureza:Min. 95%Peso molecular:235.51 g/mol4-cyclopropyl-2-fluorobenzoic acid
CAS:Versatile small molecule scaffoldFórmula:C10H9FO2Pureza:Min. 95%Peso molecular:180.17 g/mol(1-Pyridin-2-yl)piperidin-4-amine
CAS:(1-Pyridin-2-yl)piperidin-4-amine is a drug that acts as an anorexiant. It binds to the serotonin 5HT3 receptor, which is involved in the regulation of appetite and mood. It also blocks the action of serotonin at the 5HT4 receptor, which is involved in mediating intestinal motility. This agent has been shown to have a potent antagonist effect on the 1-4c alkyl group of serotonin receptors. The phenoxy group and methyl group are also responsible for binding with serotonin receptors and blocking their activity.Fórmula:C10H15N3Pureza:Min. 95%Peso molecular:177.25 g/mol2-(Chloromethyl)-4H,6H,7H-pyrano[4,3-d][1,3]thiazole
CAS:Versatile small molecule scaffoldFórmula:C7H8ClNOSPureza:Min. 95%Peso molecular:189.66 g/mol1-Boc-4-(5-Aminopyridin-2-yl)piperazine
CAS:Versatile small molecule scaffoldFórmula:C14H22N4O2Pureza:Min. 95%Peso molecular:278.35 g/molMethyl 2-(6-chloropyridin-3-yl)acetate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C8H8ClNO2Pureza:Min. 95%Peso molecular:185.61 g/moltert-Butyl 4-hydroxy-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H21NO4Pureza:Min. 95%Peso molecular:243.3 g/mol1-(3,5-Dichloro-phenyl)-propan-1-one
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H8Cl2OPureza:Min. 95%Peso molecular:203.07 g/mol5-Methyl-4-[(pyrrolidin-1-yl)methyl]-1,2-oxazole-3-carboxylic acid hydrochloride
CAS:Versatile small molecule scaffoldFórmula:C10H15ClN2O3Pureza:Min. 95%Peso molecular:246.69 g/mol2-{[(3αR,4S,6R,6αS)-6-Amino-2,2-dimethyltetrahydro-3αH-cyclopenta[d][1,3]-dioxol-4-yl] oxy}-1-ethol
CAS:Versatile small molecule scaffoldFórmula:C10H19NO4Pureza:Min. 95%Forma y color:PowderPeso molecular:217.26 g/mol1-(6-Methylpyridin-3-yl)ethanamine
CAS:Versatile small molecule scaffoldFórmula:C8H12N2Pureza:Min. 95%Peso molecular:136.19 g/mol2-[[(3aS,4R,6S,6aa)-4-[7-[[(1R,2S)-2-(3 ,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4 ,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1 ,3]dioxol-6-yl]oxy]ethanol
CAS:2-[[(3aS,4R,6S,6aa)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]- 2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol-d7 is a compound with brominated sparfloxacin. It has various applications in the field of biochemistry and research chemicals. This compound has been found to have interactions with adipocytes and adipose tissues. Additionally, it has shown potential effects on glycan metabolism and potassium ion channels. Furthermore, this compound has been studied for its potential as an herbicide and its interaction with other substances such asFórmula:C26H32F2N6O4SPureza:Min. 95%Peso molecular:562.63 g/moltert-Butyl (2S)-2-formylmorpholine-4-carboxylate
CAS:Versatile small molecule scaffoldFórmula:C10H17NO4Pureza:Min. 95%Peso molecular:215.25 g/mol2,7-Naphthyridin-1(2H)-one
CAS:<p>Cabozantinib is a small molecule that is the first to target VEGFR-2, which is a receptor tyrosine kinase involved in the development of fibrosis. Cabozantinib inhibits the activity of VEGFR-2 by binding to its ATP-binding site and blocking the phosphorylation of downstream signaling pathways. Cabozantinib has been shown to have antifibrotic properties in both preclinical and clinical models. The drug candidate has been shown to reduce kidney fibrosis in animal models. The standard dose for cabozantinib was found to be 5 mg/kg, with a maximum tolerated dose of 20 mg/kg. In vitro studies have indicated that cabozantinib binds with high affinity to the ATP-binding pocket of VEGFR-2, exhibiting competitive inhibition against other kinases such as PDGFR-beta and cKit, as well as diaryliodonium (a specific inhibitor). Caboz</p>Fórmula:C8H6N2OPureza:Min. 95%Peso molecular:146.14 g/mol6-Bromo-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C8H6BrNO2Pureza:Min. 95%Peso molecular:228.04 g/mol(3-Aminopropyl)(3-phenylpropyl)amine
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H20N2Pureza:Min. 95%Peso molecular:192.3 g/molMethyl 2-(5-bromothiophen-2-yl)acetate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C7H7BrO2SPureza:Min. 95%Peso molecular:235.1 g/mol(3-Aminobenzyl)carbamic acid tert-butyl ester
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H18N2O2Pureza:Min. 95%Peso molecular:222.28 g/mol
![2,3-Dihydro-1H-pyrrolo[3,2-c]pyridine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FYAA59628.webp&w=3840&q=75)
![3-bromo-6,7-dihydro-5h-pyrrolo[3,4-b]pyridine hcl](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FUFC11724.webp&w=3840&q=75)
![2-(Chloromethyl)-4H,6H,7H-pyrano[4,3-d][1,3]thiazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FSDC46081.webp&w=3840&q=75)
![tert-Butyl 4-hydroxy-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FXXC50503.webp&w=3840&q=75)
![5-Methyl-4-[(pyrrolidin-1-yl)methyl]-1,2-oxazole-3-carboxylic acid hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FXWB84700.webp&w=3840&q=75)
![2-{[(3αR,4S,6R,6αS)-6-Amino-2,2-dimethyltetrahydro-3αH-cyclopenta[d][1,3]-dioxol-4-yl] oxy}-1-ethol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FZKA69355.webp&w=3840&q=75)
![2-[[(3aS,4R,6S,6aa)-4-[7-[[(1R,2S)-2-(3 ,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FZKA69326.webp&w=3840&q=75)
